特宝生物
(688278)
| 流通市值：211.93亿 | | | 总市值：211.93亿 |
| 流通股本：4.08亿 | | | 总股本：4.08亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,836,563,644.13 | 797,791,349.65 | 3,695,567,867.63 | 2,479,547,947.46 |
| 营业总成本 | 1,279,195,984.7 | 608,608,067.39 | 2,481,201,979.55 | 1,721,216,914.12 |
| 其他经营收益 | | | | |
| 营业利润 | 570,743,623.65 | 198,634,338.15 | 1,250,642,983.79 | 781,386,853.42 |
| 利润总额 | 529,487,419.62 | 179,040,129.53 | 1,175,374,781.05 | 730,997,712.61 |
| 净利润 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 | 666,123,781.87 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | -81,743.32 |
| 综合收益总额 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 | 666,042,038.55 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,777,016,831.28 | 2,785,239,490.76 | 2,730,375,042.65 | 2,234,609,651.07 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,717,988,694.19 | 1,678,169,473.94 | 1,643,145,577.89 | 1,551,638,564.12 |
| 资产总计 | 4,495,005,525.47 | 4,463,408,964.7 | 4,373,520,620.54 | 3,786,248,215.19 |
| 流动负债: | | | | |
| 流动负债合计 | 587,007,730.96 | 581,301,007.88 | 707,113,916.83 | 581,467,931.59 |
| 非流动负债: | | | | |
| 非流动负债合计 | 804,201,180.12 | 251,721,991.3 | 216,828,051.17 | 195,520,357.45 |
| 负债合计 | 1,391,208,911.08 | 833,022,999.18 | 923,941,968 | 776,988,289.04 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,103,796,614.39 | 3,630,385,965.52 | 3,449,578,652.54 | 3,009,259,926.15 |
| 股东权益合计 | 3,103,796,614.39 | 3,630,385,965.52 | 3,449,578,652.54 | 3,009,259,926.15 |
| 负债和股东权益合计 | 4,495,005,525.47 | 4,463,408,964.7 | 4,373,520,620.54 | 3,786,248,215.19 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,063,712,276.19 | 1,000,052,048.52 | 3,410,862,326.35 | 2,486,230,477.48 |
| 经营活动现金流出小计 | 1,727,168,413.85 | 865,669,840.76 | 2,681,486,457.49 | 2,015,112,270.78 |
| 经营活动产生的现金流量净额 | 336,543,862.34 | 134,382,207.76 | 729,375,868.86 | 471,118,206.7 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 863,791,451.54 | 611,148,536.58 | 1,560,173,356.51 | 1,047,660,067.17 |
| 投资活动现金流出小计 | 621,870,260.59 | 341,873,480.2 | 2,060,504,603.02 | 1,347,030,768.27 |
| 投资活动产生的现金流量净额 | 241,921,190.95 | 269,275,056.38 | -500,331,246.51 | -299,370,701.1 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 621,400,000 | 41,500,000 | 195,110,178.6 | 174,439,826.4 |
| 筹资活动现金流出小计 | 884,757,456.33 | 31,647,131.23 | 262,268,038.98 | 258,357,766.87 |
| 筹资活动产生的现金流量净额 | -263,357,456.33 | 9,852,868.77 | -67,157,860.38 | -83,917,940.47 |
| 汇率变动对现金及现金等价物的影响 | -795,030.06 | -24,947.16 | -549,425.9 | -201,057.26 |
| 现金及现金等价物净增加额 | 314,312,566.9 | 413,485,185.75 | 161,337,336.07 | 87,628,507.87 |
| 期末现金及现金等价物余额 | 837,165,601.4 | 936,338,220.25 | 522,853,034.5 | 449,144,206.3 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 314,312,566.9 | - | 161,337,336.07 | - |
最新报告期：2026-09-06| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园 | 3.06 | 3.93 | 4.78 | 2026-09-06 |
| 东海证券 | 杜永宏 | 3.30 | 4.26 | 5.30 | 2026-08-31 |
| 国金证券 | 甘坛焕,马居东 | 3.04 | 4.04 | 4.89 | 2026-08-19 |
| 中国银河 | 孙怡,程培 | 2.89 | 3.62 | 4.28 | 2026-08-19 |
| 财信证券 | 吴号 | 2.82 | 3.49 | 4.19 | 2026-08-19 |